Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study

IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Journal of the Formosan Medical Association Pub Date : 2021-02-01 DOI:10.1016/j.jfma.2020.08.024
Jia-Jun Wu , Chih-Ying Wu , Ching-Yang Wu , Chih-Liang Wang , Tsung-Ying Yang , Jeng-Sen Tseng , Kuo-Hsuan Hsu , Yen-Hsiang Huang , Chung-Ping Hsu , Cheng-Yen Chuang , Chih-Hung Lin , Chien-Hua Tseng , Kun-Chieh Chen , Gee-Chen Chang
{"title":"Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study","authors":"Jia-Jun Wu ,&nbsp;Chih-Ying Wu ,&nbsp;Ching-Yang Wu ,&nbsp;Chih-Liang Wang ,&nbsp;Tsung-Ying Yang ,&nbsp;Jeng-Sen Tseng ,&nbsp;Kuo-Hsuan Hsu ,&nbsp;Yen-Hsiang Huang ,&nbsp;Chung-Ping Hsu ,&nbsp;Cheng-Yen Chuang ,&nbsp;Chih-Hung Lin ,&nbsp;Chien-Hua Tseng ,&nbsp;Kun-Chieh Chen ,&nbsp;Gee-Chen Chang","doi":"10.1016/j.jfma.2020.08.024","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Purpose</h3><p>Lung cancer patients can have advanced-stages at diagnosis, even the tumor size is ≤2 cm. We aimed to study the relationship between image characteristics, clinical, and patholoigcal results.</p></div><div><h3>Methods</h3><p>We retrospectively enrolled patients with lung adenocarcinoma at Taichung Veterans General Hospital and Chang Gung Memorial Hospital from 2007 to 2015, who were diagnosed with treatment naïve primary tumor lesions at sizes less than 2 cm, as measured by computed tomography (CT) scans. The patient was analyzed for lymph node (LN) and distant metastasis evaluation, with clinicopathological characteristics, including tumor-disappearance ratio (TDR) (tumor diameter at the mediastinal/lung window) over chest CT scans, pathological diagnosis, disease-free survival (DFS), and overall survival (OS).</p></div><div><h3>Results</h3><p>Totally 280 patients were surveyed initially and showed significantly increase of clinical LN involvement and distant metastasis when TDR ≤75% compared with &gt;75% (21.6% vs 0% for LN involvement; 27.1% vs 0% for distant metastasis; both p &lt; 0.001). We included 199 patients having surgical treatment and follow-up for the survival analysis. With a TDR ≤75%, significantly worse DFS (HR, 19.23; 95% CI, 2.60–142.01; p = 0.004) and a trend of worse OS (HR, 4.97; 95% CI, 0.61–40.61; p = 0.134) were noted by Kaplan–Meier method. TDR ≤75% revealed more advanced pathological stage, and more tumors containing micropapillary or solid subtypes when diagnosed adenocarcinoma.</p></div><div><h3>Conclusion</h3><p>For lung cancer patients with primary tumor ≤2 cm, TDR ≤75% was related to more advanced stages, the presence of micropapillary or solid components of adenocarcinoma subtypes, worse DFS, and a trend of worse OS.</p></div>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"120 2","pages":"Pages 874-882"},"PeriodicalIF":2.5000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jfma.2020.08.024","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Formosan Medical Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0929664620303983","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Purpose

Lung cancer patients can have advanced-stages at diagnosis, even the tumor size is ≤2 cm. We aimed to study the relationship between image characteristics, clinical, and patholoigcal results.

Methods

We retrospectively enrolled patients with lung adenocarcinoma at Taichung Veterans General Hospital and Chang Gung Memorial Hospital from 2007 to 2015, who were diagnosed with treatment naïve primary tumor lesions at sizes less than 2 cm, as measured by computed tomography (CT) scans. The patient was analyzed for lymph node (LN) and distant metastasis evaluation, with clinicopathological characteristics, including tumor-disappearance ratio (TDR) (tumor diameter at the mediastinal/lung window) over chest CT scans, pathological diagnosis, disease-free survival (DFS), and overall survival (OS).

Results

Totally 280 patients were surveyed initially and showed significantly increase of clinical LN involvement and distant metastasis when TDR ≤75% compared with >75% (21.6% vs 0% for LN involvement; 27.1% vs 0% for distant metastasis; both p < 0.001). We included 199 patients having surgical treatment and follow-up for the survival analysis. With a TDR ≤75%, significantly worse DFS (HR, 19.23; 95% CI, 2.60–142.01; p = 0.004) and a trend of worse OS (HR, 4.97; 95% CI, 0.61–40.61; p = 0.134) were noted by Kaplan–Meier method. TDR ≤75% revealed more advanced pathological stage, and more tumors containing micropapillary or solid subtypes when diagnosed adenocarcinoma.

Conclusion

For lung cancer patients with primary tumor ≤2 cm, TDR ≤75% was related to more advanced stages, the presence of micropapillary or solid components of adenocarcinoma subtypes, worse DFS, and a trend of worse OS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤消失率对大小≤2cm肺腺癌预后的影响:一项回顾性队列研究
背景/目的肺癌患者在诊断时,即使肿瘤大小≤2cm,也可处于晚期。我们的目的是研究图像特征、临床和病理结果之间的关系。方法回顾性纳入2007年至2015年在台中退伍军人总医院和长庚纪念医院诊断为肺腺癌的患者,这些患者的原发肿瘤病变尺寸小于2 cm,通过计算机断层扫描(CT)测量。分析患者的淋巴结(LN)和远处转移评估,临床病理特征,包括胸部CT扫描的肿瘤消失比(TDR)(纵隔/肺窗肿瘤直径),病理诊断,无病生存期(DFS)和总生存期(OS)。结果初步调查280例患者,TDR≤75%时临床LN受累和远处转移明显高于TDR≤75%时(LN受累21.6% vs LN 0%;27.1% vs 0%远处转移;p <0.001)。我们纳入199例接受手术治疗和随访的患者进行生存分析。TDR≤75%时,DFS明显变差(HR, 19.23;95% ci, 2.60-142.01;p = 0.004), OS有恶化趋势(HR, 4.97;95% ci, 0.61-40.61;p = 0.134)。TDR≤75%时,诊断为腺癌时,病理分期更晚期,肿瘤含有微乳头状或实性亚型较多。结论原发肿瘤≤2 cm的肺癌患者,TDR≤75%与分期更晚期、腺癌亚型存在微乳头状或实性成分、DFS更差、OS有更差的趋势有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.50
自引率
6.20%
发文量
381
审稿时长
57 days
期刊介绍: Journal of the Formosan Medical Association (JFMA), published continuously since 1902, is an open access international general medical journal of the Formosan Medical Association based in Taipei, Taiwan. It is indexed in Current Contents/ Clinical Medicine, Medline, ciSearch, CAB Abstracts, Embase, SIIC Data Bases, Research Alert, BIOSIS, Biological Abstracts, Scopus and ScienceDirect. As a general medical journal, research related to clinical practice and research in all fields of medicine and related disciplines are considered for publication. Article types considered include perspectives, reviews, original papers, case reports, brief communications, correspondence and letters to the editor.
期刊最新文献
Comment on "Far-infrared therapy improves cardiovascular and infectious outcomes in peritoneal dialysis patients". 2025 Taiwan guidelines on the drug therapy of lung cancer: Advanced non-squamous cell carcinoma with actionable oncogenic drivers. Beyond technical success: Optimizing patient selection for thrombectomy in stroke patients with cancer. Reply to the comment on "Long-term prognosis of complex versus simple segmentectomy for stage I non-small cell lung cancer". Far-infrared therapy: a promising strategy for reducing cardiovascular and infectious outcomes in patients undergoing peritoneal dialysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1